Controversies on corticosteroid therapy in hantavirus cardiopulmonary syndrome
Hantavirus cardiopulmonary syndrome is an emerging zoonosis in Argentina, which has low incidence but high death rates. No specific pharmacological therapy is available and symptomatic therapy is the only current alternative. This article presents the pathogenesis of hantavirus cardiopulmonary syndrome through a review of clinical experiences in neighbor South American countries, mainly Chile, and the experience acquired at the Infectious Diseases Hospital Francisco Javier Muñiz, Buenos Aires, Argentina. The role of early corticosteroid therapy is discussed taking into account that there is insufficient evidence favoring its use in the hantavirus cardiopulmonary syndrome.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
---|---|
Enthalten in: |
Medicina - 81(2021), 4 vom: 08., Seite 617-623 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Controversias sobre el uso de corticoides en el síndrome cardiopulmonar por hantavirus |
---|
Beteiligte Personen: |
Saúl, Pablo A [VerfasserIn] |
---|
Themen: |
Corticosteroids |
---|
Anmerkungen: |
Date Completed 31.08.2021 Date Revised 07.12.2022 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM329966235 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329966235 | ||
003 | DE-627 | ||
005 | 20231225210253.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||spa c | ||
028 | 5 | 2 | |a pubmed24n1099.xml |
035 | |a (DE-627)NLM329966235 | ||
035 | |a (NLM)34453805 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Saúl, Pablo A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Controversies on corticosteroid therapy in hantavirus cardiopulmonary syndrome |
246 | 3 | 3 | |a Controversias sobre el uso de corticoides en el síndrome cardiopulmonar por hantavirus |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 31.08.2021 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Hantavirus cardiopulmonary syndrome is an emerging zoonosis in Argentina, which has low incidence but high death rates. No specific pharmacological therapy is available and symptomatic therapy is the only current alternative. This article presents the pathogenesis of hantavirus cardiopulmonary syndrome through a review of clinical experiences in neighbor South American countries, mainly Chile, and the experience acquired at the Infectious Diseases Hospital Francisco Javier Muñiz, Buenos Aires, Argentina. The role of early corticosteroid therapy is discussed taking into account that there is insufficient evidence favoring its use in the hantavirus cardiopulmonary syndrome | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a corticosteroids | |
650 | 4 | |a hantavirus cardiopulmonary syndrome | |
650 | 4 | |a hantavírus | |
700 | 1 | |a Sánchez-Cunto, Milagro |e verfasserin |4 aut | |
700 | 1 | |a Gregori-Sabelli, Rosana A |e verfasserin |4 aut | |
700 | 1 | |a Chacón, Norberto R |e verfasserin |4 aut | |
700 | 1 | |a Chediack, Viviana |e verfasserin |4 aut | |
700 | 1 | |a Cunto, Eleonora R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicina |d 1945 |g 81(2021), 4 vom: 08., Seite 617-623 |w (DE-627)NLM000007854 |x 1669-9106 |7 nnns |
773 | 1 | 8 | |g volume:81 |g year:2021 |g number:4 |g day:08 |g pages:617-623 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 81 |j 2021 |e 4 |b 08 |h 617-623 |